MultiVu Video Feed: Intensive Lipitor Therapy Cuts The Risk of Hospitalizations Due to Heart Failure in Patients With Coronary Heart Disease, New Analysis Shows
Posted on: Tuesday, 6 February 2007, 12:01 CST
NEW YORK, Feb. 6 /PRNewswire/ -- Patients with coronary heart disease who took Lipitor(R) (atorvastatin calcium) 80 mg Tablets reduced the risk of hospitalizations due to heart failure compared with those patients taking the 10 mg dose of Lipitor. Lipitor 80 mg significantly reduced the risk of hospitalizations due to heart failure for patients with heart disease by 26 percent. For those with a history of heart failure, Lipitor 80 mg significantly reduced the risk by 41 percent. This new analysis of a subset of patients from the five-year TNT (Treating to New Targets) study was published in the journal Circulation.
The estimated total cost of heart failure in 2007 in the United States is $33.2 billion ($30.2 billion direct and $3 billion indirect costs). For more information visit http://www.lipitor.com/.
SATELLITE FEEDS: Tuesday, February 6th, 2007 Wednesday, February 7th, 2007 1:45 PM - 2:00 PM ET 1:30 PM - 1:45 PM ET Galaxy 26 (formerly IA6) Galaxy 26 (formerly IA6) Transponder 18 Transponder 11 C-Band C-Band Downlink Freq: 4060 Horizontal Downlink Freq: 3920 Vertical Preview and access this video on Pathfire DMG: 26677 Search within the PR Newswire or MultiVu section by story ID # 26677 or by headline For technical assistance call Pathfire Customer Care at 1-888-345-0489 or e-mail support@pathfire.com NEWS: INTENSIVE LIPITOR THERAPY CUTS RISK OF HOSPITALIZATIONS DUE TO HEART FAILURE FORMAT: News Package With Extra Soundbites and B-roll. ADDITIONAL RESOURCES: Video, contact information and more available at http://www.prnewswire.com/broadcast/26677/consumer.shtml SOUNDBITES: David Waters M.D., Professor of Medicine, University of California, San Francisco B-ROLL INCLUDES: ***Product Shots***Manufacturing Footage***Lifestyle Footage*** VIDEO PROVIDED BY: Pfizer FOR TECHNICAL INFORMATION OR HARD COPY, PLEASE CALL: MultiVu Media Relations, 800-653-5313 EXT. 3
Video: http://www.prnewswire.com/broadcast/26677/press.shtml
Pfizer
CONTACT: FOR TECHNICAL INFORMATION OR HARD COPY, PLEASE CALL: MultiVuMedia Relations, 800-653-5313, EXT. 3
Web site: http://www.lipitor.com/
Source: PRNewswire
Related Articles
- New Approach To Treating Heart Attacks Decrease Risk Of Life-threatening Complications
- Management Strategies For High Risk Stroke Patients Are Poor In A Majority Of Cases
- Whole Grains Decrease Heart Failure Risk
- Study Supports Possible Use of Leukine(R) As a Potential Adjuvant Therapy for High-Risk Melanoma Patients
- Patient Safety in Hospitals Shows Five Consecutive Years of Improvement, According to Thomson Healthcare Study
- Data393 Raises $22,000 to Benefit Former Patients of Craig Hospital
- Aspirin Useful in Reducing Stroke Risk of Patients With Establishedheart Disease: Study
- NitroMed Announces Launch of BiDil(R) for the Treatment of Heart Failure in Black Patients
- Vitamin E Supplements Might Increase Heart Failure Risks Forcertain Patients
- Spacewalk Suspended Due to Technical Reason
 |
 |
User Comments (0)
RSS Feeds